359 related articles for article (PubMed ID: 29476865)
1. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
Bal-Price A; Pistollato F; Sachana M; Bopp SK; Munn S; Worth A
Toxicol Appl Pharmacol; 2018 Sep; 354():7-18. PubMed ID: 29476865
[TBL] [Abstract][Full Text] [Related]
2. Current Availability of Stem Cell-Based In Vitro Methods for Developmental Neurotoxicity (DNT) Testing.
Fritsche E; Barenys M; Klose J; Masjosthusmann S; Nimtz L; Schmuck M; Wuttke S; Tigges J
Toxicol Sci; 2018 Sep; 165(1):21-30. PubMed ID: 29982830
[TBL] [Abstract][Full Text] [Related]
3. The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays.
Sachana M; Willett C; Pistollato F; Bal-Price A
Reprod Toxicol; 2021 Aug; 103():159-170. PubMed ID: 34147625
[TBL] [Abstract][Full Text] [Related]
4. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
Fritsche E; Grandjean P; Crofton KM; Aschner M; Goldberg A; Heinonen T; Hessel EVS; Hogberg HT; Bennekou SH; Lein PJ; Leist M; Mundy WR; Paparella M; Piersma AH; Sachana M; Schmuck G; Solecki R; Terron A; Monnet-Tschudi F; Wilks MF; Witters H; Zurich MG; Bal-Price A
Toxicol Appl Pharmacol; 2018 Sep; 354():3-6. PubMed ID: 29447839
[TBL] [Abstract][Full Text] [Related]
5. An industry perspective: A streamlined screening strategy using alternative models for chemical assessment of developmental neurotoxicity.
Li J; Settivari R; LeBaron MJ; Marty MS
Neurotoxicology; 2019 Jul; 73():17-30. PubMed ID: 30786249
[TBL] [Abstract][Full Text] [Related]
6. Towards a regulatory use of alternative developmental neurotoxicity testing (DNT).
Terron A; Bennekou SH
Toxicol Appl Pharmacol; 2018 Sep; 354():19-23. PubMed ID: 29454059
[TBL] [Abstract][Full Text] [Related]
7. Assessment of developmental neurotoxicity induced by chemical mixtures using an adverse outcome pathway concept.
Pistollato F; de Gyves EM; Carpi D; Bopp SK; Nunes C; Worth A; Bal-Price A
Environ Health; 2020 Feb; 19(1):23. PubMed ID: 32093744
[TBL] [Abstract][Full Text] [Related]
8. A better approach to in vivo developmental neurotoxicity assessment: Alignment of rodent testing with effects seen in children after neurotoxic exposures.
Vorhees CV; Sprowles JN; Regan SL; Williams MT
Toxicol Appl Pharmacol; 2018 Sep; 354():176-190. PubMed ID: 29544898
[TBL] [Abstract][Full Text] [Related]
9. Rotenone exerts developmental neurotoxicity in a human brain spheroid model.
Pamies D; Block K; Lau P; Gribaldo L; Pardo CA; Barreras P; Smirnova L; Wiersma D; Zhao L; Harris G; Hartung T; Hogberg HT
Toxicol Appl Pharmacol; 2018 Sep; 354():101-114. PubMed ID: 29428530
[TBL] [Abstract][Full Text] [Related]
10. Design and validation of an ontology-driven animal-free testing strategy for developmental neurotoxicity testing.
Hessel EVS; Staal YCM; Piersma AH
Toxicol Appl Pharmacol; 2018 Sep; 354():136-152. PubMed ID: 29544899
[TBL] [Abstract][Full Text] [Related]
11. Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells.
Menzner AK; Abolpour Mofrad S; Friedrich O; Gilbert DF
Toxicology; 2015 Dec; 338():69-76. PubMed ID: 26498558
[TBL] [Abstract][Full Text] [Related]
12. Editorial: Developmental neurotoxicity.
Bal-Price A; Fritsche E
Toxicol Appl Pharmacol; 2018 Sep; 354():1-2. PubMed ID: 30030094
[No Abstract] [Full Text] [Related]
13. Assessment of neurotransmitter release in human iPSC-derived neuronal/glial cells: a missing in vitro assay for regulatory developmental neurotoxicity testing.
Cervetto C; Pistollato F; Amato S; Mendoza-de Gyves E; Bal-Price A; Maura G; Marcoli M
Reprod Toxicol; 2023 Apr; 117():108358. PubMed ID: 36863571
[TBL] [Abstract][Full Text] [Related]
14. Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.
Bal-Price A; Hogberg HT; Crofton KM; Daneshian M; FitzGerald RE; Fritsche E; Heinonen T; Hougaard Bennekou S; Klima S; Piersma AH; Sachana M; Shafer TJ; Terron A; Monnet-Tschudi F; Viviani B; Waldmann T; Westerink RHS; Wilks MF; Witters H; Zurich MG; Leist M
ALTEX; 2018; 35(3):306-352. PubMed ID: 29485663
[TBL] [Abstract][Full Text] [Related]
15. International Regulatory and Scientific Effort for Improved Developmental Neurotoxicity Testing.
Sachana M; Bal-Price A; Crofton KM; Bennekou SH; Shafer TJ; Behl M; Terron A
Toxicol Sci; 2019 Jan; 167(1):45-57. PubMed ID: 30476307
[TBL] [Abstract][Full Text] [Related]
16. Developmental neurotoxicity of different pesticides in PC-12 cells in vitro.
Christen V; Rusconi M; Crettaz P; Fent K
Toxicol Appl Pharmacol; 2017 Jun; 325():25-36. PubMed ID: 28385489
[TBL] [Abstract][Full Text] [Related]
17. A perspective on In vitro developmental neurotoxicity test assay results: An expert panel review.
Juberg DR; Fox DA; Forcelli PA; Kacew S; Lipscomb JC; Saghir SA; Sherwin CM; Koenig CM; Hays SM; Kirman CR
Regul Toxicol Pharmacol; 2023 Sep; 143():105444. PubMed ID: 37442267
[TBL] [Abstract][Full Text] [Related]
18. Revolutionizing developmental neurotoxicity testing - a journey from animal models to advanced in vitro systems.
Smirnova L; Hogberg HT; Leist M; Hartung T
ALTEX; 2024; 41(2):152-178. PubMed ID: 38579692
[TBL] [Abstract][Full Text] [Related]
19. An analysis of the limitations and uncertainties of in vivo developmental neurotoxicity testing and assessment to identify the potential for alternative approaches.
Paparella M; Bennekou SH; Bal-Price A
Reprod Toxicol; 2020 Sep; 96():327-336. PubMed ID: 32781019
[TBL] [Abstract][Full Text] [Related]
20. Don't judge a neuron only by its cover: neuronal function in in vitro developmental neurotoxicity testing.
de Groot MW; Westerink RH; Dingemans MM
Toxicol Sci; 2013 Mar; 132(1):1-7. PubMed ID: 22961093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
